MEMPHIS, Tenn., Feb. 24, 2005 (PRIMEZONE) -- The U.S. Defense Department has awarded $750,000 to Greystone Medical Group and the University of Tennessee Health Science Center (UTHSC) to complete pre-clinical research of a drug to treat hemorrhagic shock.
